
    
      This project includes 30 patients with bone metastases on high dose antiresorptive treatment
      (HDAR) for the prevention of bone complications. Definition of HDAR refers to the
      antiresorptive dose used per label in cancer patients with bone metastases to prevent bone
      complications.
    
  